Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
31 Maggio 2022 - 2:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE
ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-39708
OTR ACQUISITION CORP
(Exact name of registrant as specified in its
charter)
12 Gill Street
Suite 4650
Woburn, Massachusetts
(617) 871-2101
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Units, each consisting of one share of Class A
common stock and one-half of one redeemable Warrant
Class A common stock, par value $0.0001
per share
Warrants, each whole warrant exercisable for
one share of Class A common stock at an exercise price of
$11.50 per share
(Title of each class of securities covered by
this Form)
None
(Titles of all other classes of securities for
which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1) |
x |
|
|
Rule 12g-4(a)(2) |
¨ |
|
|
Rule 12h 3(b)(1)(i) |
x |
|
|
Rule 12h-3(b)(1)(ii) |
¨ |
|
|
Rule 15d-6 |
¨ |
|
|
Rule 15d-22(b) |
¨ |
|
Approximate number of holders of record as of the certification or
notice date: One (1)*.
* |
Effective May 19, 2022, a subsidiary of Comera Life Sciences Holdings, Inc. merged with and into OTR Acquisition Corp., with OTR Acquisition Corp. surviving such merger and becoming a wholly owned subsidiary of Comera Life Sciences Holdings, Inc. |
Pursuant to the requirements of the Securities Exchange Act of 1934,
OTR Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: May 31, 2022 |
By: |
/s/ Jeff Hackman |
|
|
Name: |
/s/ Jeff Hackman |
|
|
Title: |
Chairman & CEO |
Grafico Azioni Comera Life Sciences (NASDAQ:CMRA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Comera Life Sciences (NASDAQ:CMRA)
Storico
Da Giu 2023 a Giu 2024